Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT04734990 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia-0
Chronic Myelomonocytic Leukemia-1
Chronic Myelomonocytic Leukemia-2
Myelodysplastic Syndrome
Recurrent Chronic Myelomonocytic Leukemia
Recurrent Myelodysplastic Syndrome

Interventions

DRUG: Azacitidine
DRUG: Seclidemstat

Sponsor

M.D. Anderson Cancer Center